Hereditary spastic paraplegia-like disorder due to a mitochondrial ATP6 gene point mutation

Mitochondrion
Christophe VernyVincent Procaccio

Abstract

Hereditary spastic paraplegia refers to a genetically heterogeneous syndrome. We identified five members of a family suffering from a late-onset spastic paraplegia-like disorder, carrying the homoplasmic m.9176 T>C mutation in the mitochondrial ATP6 gene. The clinical severity of the disease observed in the family was correlated with the biochemical and assembly defects of the ATP synthase. The m.9176 T>C mutation has been previously associated to Leigh syndrome or familial bilateral striatal necrosis. Other factors such as modifying genes may be involved in the phenotypic expression of the disease. The family belongs to the mitochondrial haplogroup J, previously shown to play a role in modulating the phenotype of mitochondrial diseases and be associated with longevity. Moreover other nuclear modifying genes or environmental factors may contribute to the disease phenotype. This finding extends the genetic heterogeneity of the hereditary spastic paraplegia together with the clinical spectrum of mutations of the ATP6 gene.

References

Nov 26, 1999·Gene·D C WallaceM T Lott
Apr 25, 2000·The EMBO Journal·H Schägger, K Pfeiffer
Sep 26, 2001·European Journal of Human Genetics : EJHG·G RoseG De Benedictis
Jan 22, 2004·American Journal of Medical Genetics. Part a·Andrea GropmanLee-Jun C Wong
Dec 21, 2005·Annals of Neurology·Rosalba CarrozzoHermann Schägger
Nov 24, 2006·The Journal of Biological Chemistry·Paulina Cortés-HernándezJosé J García
Dec 21, 2006·Nucleic Acids Research·Eduardo Ruiz-PesiniDouglas C Wallace
Apr 5, 2007·Nature Protocols·Ilka WittigHermann Schägger
Apr 21, 2007·Annals of Neurology·Dominique LoiseauPascal Reynier
May 23, 2008·Annals of Neurology·Arnaud ChevrollierPascal Reynier
Jun 21, 2008·Human Mutation·Marty C BrandonDouglas C Wallace
Jul 16, 2008·Biochimica Et Biophysica Acta·Roza KucharczykJean-Paul di Rago
Jan 23, 2009·Journal of Cellular Biochemistry·Martha Elisa Vazquez-MemijeRosalba Carrozzo
Feb 3, 2009·Molecular Genetics and Metabolism·Prasanth PotluriVincent Procaccio
Jun 2, 2009·Molecular Genetics and Metabolism·Yelena BykhovskayaNathan Fischel-Ghodsian
Jun 16, 2009·Brain : a Journal of Neurology·Matthew Anthony KirkmanPatrick Francis Chinnery
Oct 31, 2009·Human Molecular Genetics·M D'AurelioG Manfredi
Jan 9, 2010·Biochimica Et Biophysica Acta·Roza KucharczykJean-Paul di Rago
Jan 19, 2010·Annual Review of Pathology·Douglas C WallaceVincent Procaccio

❮ Previous
Next ❯

Citations

Jul 3, 2013·Journal of Neurology·Kishore R KumarCarolyn M Sue
Aug 30, 2011·Journal of Inherited Metabolic Disease·An I JonckheereRichard J T Rodenburg
Jan 5, 2013·Toxicological Sciences : an Official Journal of the Society of Toxicology·Eleonora NapoliCecilia Giulivi
Sep 14, 2012·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·Matthis SynofzikLudger Schöls
May 6, 2014·Revue neurologique·A Chaussenot, V Paquis-Flucklinger
Jul 5, 2011·Journal of Neurology·Elena Sánchez-FerreroVictoria Alvarez
Jul 6, 2014·Human Molecular Genetics·Ester López-GallardoJulio Montoya
Jun 24, 2014·Experimental Neurology·Temistocle Lo GiudiceAntonio Orlacchio
Mar 15, 2015·Mitochondrion·María M O'CallaghanRafael Artuch
May 5, 2012·Journal of the Neurological Sciences·Josef FinstererGiovanni Stevanin
Mar 19, 2014·Experimental Cell Research·Anne NoreauGuy A Rouleau
Jun 9, 2016·The Cerebellum·Paulo Victor Sgobbi de SouzaAcary Souza Bulle Oliveira
Jul 14, 2016·Molecular Genetics and Metabolism Reports·Miguel ChuquilinEsperanza Font-Montgomery
Aug 23, 2016·Molecular Genetics and Metabolism Reports·Miguel ChuquilinEsperanza Font Montgomery
Feb 1, 2017·Brain : a Journal of Neurology·Alejandro Estrada-CuzcanoRebecca Schüle
Feb 12, 2020·Neurology. Genetics·Enrico BugiardiniRobert D S Pitceathly
Mar 29, 2014·Arquivos de neuro-psiquiatria·Ingrid FaberMarcondes C França
Mar 27, 2018·Neurology. Genetics·Christian G BouwkampSteven A Kushner
Apr 20, 2018·Frontiers in Physiology·Alain DautantRoza Kucharczyk
Aug 24, 2018·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Yanping Wei, Lin Wang
Mar 2, 2019·Current Neurology and Neuroscience Reports·Maxime BoutryGiovanni Stevanin
Jan 28, 2021·Human Genome Variation·Takenori TozawaTomohiro Chiyonobu
Apr 17, 2017·European Journal of Medical Genetics·Christopher B JacksonAndré Schaller
Dec 17, 2020·Seminars in Cell & Developmental Biology·Aksu GunayP Hande Ozdinler
Aug 29, 2020·Mitochondrion·Benoit RuchetonAnne Lombès
May 27, 2021·Journal of Neurology·Dagmar NolteUlrich Müller
Oct 13, 2021·Movement Disorders : Official Journal of the Movement Disorder Society·Derek E NeilsonTaosheng Huang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxias (MDS)

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Ataxia

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

ATP Synthases

ATP synthases are enzymes located in the inner mitochondrial membrane that catalyze the synthesis of ATP during cellular respiration. Discover the latest research on ATP synthases here.

Ataxias

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on different types of ataxias here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.